Inogen completed the acquisition of Physio-Assist from Merieux Equity Partners and Turenne Groupe for $45m.

Inogen, a medical technology company, completed the acquisition of Physio-Assist, a manufacturer of healthcare devices, from Merieux Equity Partners and Turenne Groupe, two private equity firms, for $45m. “This acquisition aligns with our strategy to diversify our portfolio to globally improve patient lives through respiratory care. Simeox imminently expands our product offering in EMEA, and potentially in the US to serve COPD and other chronic disease patients who suffer from bronchiectasis with an innovative, non-invasive, and next generation airway clearance solution. We believe this is a compelling transaction, as it expands our addressable market opportunity, enhances our long-term growth and profitability, and is expected to generate an attractive return on investment," Nabil Shabshab, Inogen President and Chief Executive Officer.